CY1109666T1 - Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας - Google Patents

Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας

Info

Publication number
CY1109666T1
CY1109666T1 CY20091101312T CY091101312T CY1109666T1 CY 1109666 T1 CY1109666 T1 CY 1109666T1 CY 20091101312 T CY20091101312 T CY 20091101312T CY 091101312 T CY091101312 T CY 091101312T CY 1109666 T1 CY1109666 T1 CY 1109666T1
Authority
CY
Cyprus
Prior art keywords
racoidis
therapeutic
disease treatment
treatment
uveitis
Prior art date
Application number
CY20091101312T
Other languages
Greek (el)
English (en)
Inventor
Peter G Klimko
Mark R Hellberg
Daniel A Gamache
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of CY1109666T1 publication Critical patent/CY1109666T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
CY20091101312T 2004-05-14 2009-12-16 Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας CY1109666T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57116204P 2004-05-14 2004-05-14
EP05751168A EP1744736B1 (en) 2004-05-14 2005-05-12 Method of treating dry eye disorders and uveitis

Publications (1)

Publication Number Publication Date
CY1109666T1 true CY1109666T1 (el) 2014-08-13

Family

ID=34968761

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101312T CY1109666T1 (el) 2004-05-14 2009-12-16 Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας

Country Status (19)

Country Link
US (1) US20050256189A1 (enExample)
EP (1) EP1744736B1 (enExample)
JP (2) JP4993299B2 (enExample)
KR (1) KR101170885B1 (enExample)
CN (1) CN100522147C (enExample)
AT (1) ATE448779T1 (enExample)
AU (1) AU2005244839B2 (enExample)
BR (1) BRPI0511125A (enExample)
CA (1) CA2563659C (enExample)
CY (1) CY1109666T1 (enExample)
DE (1) DE602005017762D1 (enExample)
DK (1) DK1744736T3 (enExample)
ES (1) ES2334368T3 (enExample)
MX (1) MXPA06013170A (enExample)
PL (1) PL1744736T3 (enExample)
PT (1) PT1744736E (enExample)
SI (1) SI1744736T1 (enExample)
WO (1) WO2005112905A1 (enExample)
ZA (1) ZA200609220B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005304733B2 (en) 2004-11-09 2011-04-07 Alcon, Inc. 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
US7687539B1 (en) 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
JP2013521230A (ja) * 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
WO2012112873A2 (en) 2011-02-18 2012-08-23 3M Innovative Properties Company Flexible light emitting semiconductor device
KR102593305B1 (ko) * 2020-11-25 2023-10-25 서울대학교 산학협력단 인공지능 기반 의류 사이즈 추천 방법 및 시스템

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) * 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
EP0459148B1 (en) * 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5441951A (en) * 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
EP1237549B1 (en) * 1999-11-09 2004-02-04 Alcon, Inc Lipoxin a4 and analogues for the treatment of dry eye

Also Published As

Publication number Publication date
KR101170885B1 (ko) 2012-08-07
WO2005112905A1 (en) 2005-12-01
ES2334368T3 (es) 2010-03-09
JP4993299B2 (ja) 2012-08-08
AU2005244839A2 (en) 2005-12-01
EP1744736B1 (en) 2009-11-18
CA2563659A1 (en) 2005-12-01
PL1744736T3 (pl) 2010-03-31
EP1744736A1 (en) 2007-01-24
JP2012107053A (ja) 2012-06-07
CN1953740A (zh) 2007-04-25
AU2005244839B2 (en) 2009-12-24
DK1744736T3 (da) 2010-02-15
MXPA06013170A (es) 2007-02-13
US20050256189A1 (en) 2005-11-17
DE602005017762D1 (de) 2009-12-31
ATE448779T1 (de) 2009-12-15
KR20070011582A (ko) 2007-01-24
CN100522147C (zh) 2009-08-05
JP2007537282A (ja) 2007-12-20
PT1744736E (pt) 2010-01-05
ZA200609220B (en) 2009-02-25
SI1744736T1 (sl) 2010-01-29
AU2005244839A1 (en) 2005-12-01
CA2563659C (en) 2012-03-20
BRPI0511125A (pt) 2007-11-27

Similar Documents

Publication Publication Date Title
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
CY1118768T1 (el) Ετεροκυκλικοι ρυθμιστες μεταφορεων κασετας συνδεσης atp
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
EA201791669A2 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
ATE469880T1 (de) Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendung
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
NO20076405L (no) Anvendelse av 24-nor-UDCA
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
CY1107562T1 (el) Χρηση των ν-(2-αρυλ-προπιονυλ)-σουκλφοναμιδιων για τη θepαπεια του τραυματος του νωτιαιου μυελου
ATE411279T1 (de) Arylsulfonamidobenzylverbindungen
WO2006023452A3 (en) Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
PL1979521T3 (pl) Nowy sposób impregnowania powierzchni tekstylnych
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
EA200702534A1 (ru) Применение бензоильного производного 3-аминокарбазола для лечения расстройства, связанного с продукцией простагландина e2(pge2)